Trials / Unknown
UnknownNCT05079295
Management of Anticoagulants and Antithrombotics in Patients With CSDH
Thromboembolic and Hemorrhagic Risk Evaluation in Surgically Treated Patients With CSDH Taking Anticoagulants and Antithrombotics
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- University Hospital of Ferrara · Academic / Other
- Sex
- All
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
Primary objective of the study will be to compare, up to 6 months after surgery, number of relapses (post operative re-bleeding) or intracerebral hemorrhage (others than subdural hematomas) and thromboembolic or cardiovascular ischemic events, in patients undergoing surgery for chronic subdural hematoma (CSDH). These data will be correlated to the suspension or not of antithrombotics or anticoagulants before surgery or their re-introduction after surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | CSDH evacuation | Burr hole for chronic subdural hematomas |
Timeline
- Start date
- 2021-02-20
- Primary completion
- 2023-02-20
- Completion
- 2024-02-20
- First posted
- 2021-10-15
- Last updated
- 2022-11-03
Locations
1 site across 1 country: Italy
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05079295. Inclusion in this directory is not an endorsement.